Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Measurement of human latent Transforming Growth Factor-β1 using a latency associated protein-reactive ELISA.

Areström I, Zuber B, Bengtsson T, Ahlborg N.

J Immunol Methods. 2012 May 31;379(1-2):23-9. doi: 10.1016/j.jim.2012.02.016. Epub 2012 Mar 1.

2.
3.

Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.

Glinka Y, Prud'homme GJ.

J Leukoc Biol. 2008 Jul;84(1):302-10. doi: 10.1189/jlb.0208090. Epub 2008 Apr 24.

4.

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

Böttinger EP, Factor VM, Tsang ML, Weatherbee JA, Kopp JB, Qian SW, Wakefield LM, Roberts AB, Thorgeirsson SS, Sporn MB.

Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5877-82.

8.

Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex.

Walton KL, Makanji Y, Chen J, Wilce MC, Chan KL, Robertson DM, Harrison CA.

J Biol Chem. 2010 May 28;285(22):17029-37. doi: 10.1074/jbc.M110.110288. Epub 2010 Mar 22.

9.

Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.

Yang Y, Dignam JD, Gentry LE.

Biochemistry. 1997 Sep 30;36(39):11923-32.

PMID:
9305986
10.

Transforming growth factor beta-1 and beta-2 in human tear fluid.

Gupta A, Monroy D, Ji Z, Yoshino K, Huang A, Pflugfelder SC.

Curr Eye Res. 1996 Jun;15(6):605-14.

PMID:
8670763
11.

Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation.

Ehrhart EJ, Segarini P, Tsang ML, Carroll AG, Barcellos-Hoff MH.

FASEB J. 1997 Oct;11(12):991-1002.

PMID:
9337152
12.

Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.

Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, Taylor SE, Ledbetter S, Lawrence CM, Rifkin DB, Barcellos-Hoff MH.

Radiat Res. 2006 Dec;166(6):839-48.

PMID:
17149983
13.

Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland.

Yoshino K, Garg R, Monroy D, Ji Z, Pflugfelder SC.

Curr Eye Res. 1996 Jun;15(6):615-24.

PMID:
8670764
14.

Regulation of transforming growth factor beta1 by nitric oxide.

Vodovotz Y, Chesler L, Chong H, Kim SJ, Simpson JT, DeGraff W, Cox GW, Roberts AB, Wink DA, Barcellos-Hoff MH.

Cancer Res. 1999 May 1;59(9):2142-9.

15.

Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent.

Ghahary A, Tredget EE, Ghahary A, Bahar MA, Telasky C.

Wound Repair Regen. 2002 Sep-Oct;10(5):328-35.

PMID:
12406170
16.
17.

Asbestos-derived reactive oxygen species activate TGF-beta1.

Pociask DA, Sime PJ, Brody AR.

Lab Invest. 2004 Aug;84(8):1013-23.

18.
19.
20.

TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes.

Kunzmann S, Wright JR, Steinhilber W, Kramer BW, Blaser K, Speer CP, Schmidt-Weber C.

Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L747-56. Epub 2006 Apr 28.

Supplemental Content

Support Center